Cardio Diagnostics shares surge 41.12% premarket after announcing Southdale YMCA partnership and India market expansion with PrecisionCHD test.

Cardio Diagnostics surged 41.12% in premarket trading following two major strategic announcements. The company expanded its U.S. market presence through a partnership with Southdale YMCA to deliver AI-powered cardiovascular testing and education in Minnesota, the second such collaboration with a YMCA. Simultaneously, it announced its first international expansion into India via a strategic alliance with Aimil Ltd. and Dr. Lal PathLabs to launch its PrecisionCHD™ test, marking entry into a high-growth market with significant cardiovascular disease prevalence. Both developments underscore the company’s growth strategy, enhancing accessibility to its AI-driven diagnostics and expanding into new geographic regions, which likely drove investor optimism.